- Paperback: 192 pages
- Publisher: Diamedica; 1 edition (May 22, 2012)
- Language: English
- ISBN-10: 098232197X
- ISBN-13: 978-0982321973
- Product Dimensions: 9 x 6.1 x 0.7 inches
- Shipping Weight: 11.2 ounces
- Average Customer Review: 7 customer reviews
- Amazon Best Sellers Rank: #1,545,113 in Books (See Top 100 in Books)
Enter your mobile number or email address below and we'll send you a link to download the free Kindle App. Then you can start reading Kindle books on your smartphone, tablet, or computer - no Kindle device required.
To get the free app, enter your mobile phone number.
Cancer Clinical Trials: A Commonsense Guide to Experimental Cancer Therapies and Clinical Trials 1st Edition
Use the Amazon App to scan ISBNs and compare prices.
The Amazon Book Review
Author interviews, book reviews, editors picks, and more. Read it now
"The is the one book that any patient contemplating entry into a clinical trial should read. It clearly demonstrates the value of clinical research, without overwhelming the reader who is already dealing with difficult medical issues." -Kidney Cancer Association CEO Bill Bro
VERDICT Patients considering enrolling in a cancer clinical trial will find this book helpful for understanding the process and their rights as a participant. Library Journal Dana Ladd, Community Health Education Ctr., Virginia Commonwealth Univ. Libs. & Virginia Commonwealth Univ. Health Syst., Richmond
From the Author
Every person diagnosed with cancer should have knowledge both about their disease and also about clinical trials. Cancer clinical trials are changing the way cancer is treated and a clinical trial might be on option for treatment at any stage of cancer. Armed with knowledge and understanding people fighting cancer can make the best decisions about their cancer care, including decisions about whether a clinical trial might be worthy of consideration. In an interview with Andrew Schorr of Patient Power, I get a chance to discuss why I am so passionate about this book. Please visit my author page to view the interview and learn more.
Browse award-winning titles. See more
Top customer reviews
There was a problem filtering reviews right now. Please try again later.
Why might that be? One glaring difference is the rate of participation in cancer clinical trials. The vast majority of children in the US receive their cancer care as part of a clinical trial. But the clinical trial participation rate among young adults is less than 5%. If we are to engineer improvements for this group, we must increase participation in cancer clinical trials.
Clearing up misconceptions about cancer clinical trials, and aiding patients as they decide about participation in cancer clinical trials, is critical to that work, and Cancer Clinical Trials is a valuable tool to guide people through this process. This book is both comprehensive and easy to use, with direct questions asked and answered, misconceptions you may encounter highlighted, and samples practical items like billing schedules and insurance letters provided. In the end, readers are invited to join the authors, and advocates like myself, into this cancer fighting community.
Brandon Hayes-Lattin, MD
Senior Medical Advisor, LIVESTRONG
Medical Director, Adolescent and Young Adult Oncology Program
Associate Professor of Medicine
Oregon Health and Science University, Knight Cancer Institute
Every cancer patient interested in a clinical trial should understand the key concepts outlined in this book. The authors explain complicated technical terms and procedures in simple, clear language and take away some of the anxiety associated with the unknown.